NuScale Power Stock: Can SMR Reach $120 by 2028?

NuScale Power (SMR) returned to headlines on May 10, 2026 after renewed market chatter about a $120 per-share price target surfaced in retail and sell-side commentary, prompting institutional scrutiny of the valuation mechanics behind that figure (Yahoo Finance, May 10, 2026). A move to $120 from current levels would represent a materially higher multiple and a re-pricing of the small modular reactor (SMR) opportunity relative to incumbent nuclear services and heavy-equipment players. Investors and analysts asking whether SMR can get to $120 must reconcile near-term execution risk—project financing, NRC approvals and supply-chain scale-up—with long-term demand assumptions around decarbonization and baseload capacity. This piece lays out the contextual backdrop, a data-driven scenario analysis with specific numeric assumptions, and a risk-weighted assessment that institutional allocators can use to frame further diligence.

Context

NuScale designs and commercializes small modular reactors intended to serve baseload and industrial power markets; the company has been one of the most visible pure plays on SMRs since its public listing. The SMR sector sits at the intersection of energy security and decarbonization policy: in the U.S., federal and state incentives plus direct Department of Energy engagement have accelerated project-level activity but have not eliminated financing or regulatory risk. As of May 10, 2026, broader market conditions—credit spreads, 10-year Treasury yields and construction-cost inflation—remain key determinants of project economics. These macro variables affect not only project-level returns but also the multiple the market is willing to assign to future revenue streams from multi-decade power contracts.

NuScale's commercial timetable and backlog cadence are essential to any valuation scenario. The company has emphasized staged revenue from engineering, procurement and construction (EPC) services, licensing fees, and recurring operations-plus-maintenance contracts. For analysts, converting those revenue streams into an equity valuation requires explicit assumptions about: commissioning schedules (calendar-year targets for first-of-a-kind units), contract length and pricing, capital-intensity per MW of installed SMR capacity, and the company’s ability to secure long-term purchase agreements. Absent a clear, contract-level pipeline with committed offtake and financing, equity upside remains contingent on execution milestones rather than pure technology adoption.

Finally, peer and benchmark behavior matters. Public nuclear-services and reactor-component firms such as BWXT (BWXT) provide partial comparables on manufacturing and long-cycle contracting, while integrated utilities and EPC firms show how project risk can compress margins and extend payback. Investors will therefore compare NuScale’s implied growth and margin profile against companies with established nuclear construction revenue and against green-hydrogen and battery storage names that also compete for decarbonization capital.

Data Deep Dive

Three specific data points anchor our scenario analysis. First, the topline market trigger: the Yahoo Finance piece dated May 10, 2026 flagged renewed commentary about a $120 target for NuScale (Yahoo Finance, May 10, 2026). Second, share-count and scenario math: using an illustrative share count of 135 million fully diluted shares (management disclosures and recent SEC filings indicate share counts in the low-to-mid hundreds of millions range; analysts should confirm the exact figure in the latest 10-Q/10-K), a $120 share price implies an equity market capitalization near $16.2 billion (120 x 135m = $16.2bn). Third, project economics sensitivity: if a single NuScale SMR plant delivers 300–600 MW of nameplate capacity and is contracted at $60–$90/MWh under 20–40 year offtake agreements, discounted cash flow conversions materially affect valuation — a 100-basis-point change in the real discount rate can swing net present value per plant by tens to hundreds of millions of dollars. Sources: Yahoo Finance (May 10, 2026), company SEC filings (latest 10-Q/10-K), and independent power-market modelling conventions.

Beyond the headline, comparative valuation matters. To justify a $16bn+ market capitalization, NuScale would need to convert pipeline estimates into multi-GW of operating capacity and secure long-term margins close to those of established EPCs rather than early-stage technology developers. For context, if the company recognizes $500m of revenue annually with enterprise margins in the 15–25% range by the mid-2030s, the market would be pricing elevated secular growth and durability into the equity multiple. Conversely, delayed deliveries, fixed-price contract overruns, or higher-than-expected capital costs would compress multiples quickly; historical nuclear-project overruns highlight how sensitive equity returns are to construction execution.

Sector Implications

A re-rating of NuScale toward a $120 target would have broader implications for the SMR sector and for public markets’ appetite for long-duration energy infrastructure equities. First, it would imply investor confidence not only in NuScale’s technology but in the broader project finance ecosystem that must underwrite multi-decade power contracts. That confidence would likely translate to increased M&A interest from utilities and industrial partners seeking intellectual property and turnkey capability. Second, a higher valuation would recalibrate cost-of-capital assumptions across SMR competitors: suppliers with shorter lead times or lower capital intensity would see their relative valuations benefit if the market begins to reward demonstrable execution.

Relative-to-peers, NuScale’s path to scale must be faster than typical utility-scale renewables projects because SMR economics rely on capacity factors and long-term baseload pricing. Compared with large nuclear builds that historically suffered multi-year delays and 20–50% cost overruns, SMRs aim to modularize and standardize components to reduce execution risk. Empirical evidence to date is limited, and investors should require third-party engineering validation and fixed-price EPC contracts to materially reduce uncertainty. The market’s discount for technology execution risk is therefore a central variable in assessing whether a $120 price is credible.

Policy catalysts could tilt the odds. Federal loan guarantees, clean-energy procurement targets, and carbon pricing would materially improve cash-flow certainty for SMR projects: for example, a 10-year production tax credit or a guaranteed revenue floor under a public offtake agreement would reduce the discount rate applied to future cash flows. Conversely, regulatory or political setbacks in key states or countries would reduce potential market size and increase the time to achieve the revenue base implied by a $120 valuation.

Risk Assessment

Execution risk is the dominant risk type. For NuScale to reach $120, it must successfully manage serial manufacturing, licensing timelines with the Nuclear Regulatory Commission (NRC), and first-of-a-kind learning curves. Historical analogs in nuclear and large infrastructure show that first-of-a-kind projects frequently face schedule slippage; each month of delay increases financing costs and compresses IRR. Counter-parties such as EPC contractors and heavy-equipment suppliers must also scale, and any single-vendor failure can cascade into multi-quarter delays.

Market risk is the second key domain. Electrification and industrial decarbonization rates will determine demand for baseload SMR capacity. If merchant power prices remain low because of oversupply from renewables plus storage, the price that offtakers are willing to pay for guaranteed baseload will be constrained. Scenario exercises show that a 20% lower contract price or a 200-basis-point higher discount rate reduces the PV of future cash flows to equity holders by a material %, potentially moving valuations well below the $120 scenario.

Regulatory and political risk are non-trivial. Public acceptance, waste management policy, and state-level procurement processes can extend timelines. While federal support reduces some of this risk, it does not eliminate it: conditionality in grants, cost-sharing agreements, and political changes can alter the effective economics of projects already under development. Investors should model contingent outcomes and stress-test valuation scenarios under delayed-build and partial-commission scenarios.

Fazen Markets Perspective

Fazen Markets views a $120 per-share outcome for NuScale as an aspirational but not impossible scenario that requires a confluence of favorable events: multiple firm offtake contracts, demonstrable first-unit cost containment, and continued policy tailwinds that lower financing costs. Our contrarian insight is that the market could re-rate NuScale more rapidly if it secures one or two sizable utility offtakes with long tenors and indexed pricing — those contracts act as binary events that convert pipeline narratives into bankable cash flows. Conversely, we view headline price-target talk divorced from contract-level detail as an unreliable guide to near-term performance.

From a risk-adjusted standpoint, institutional allocations should separate technology risk from project-financing risk. The former declines as design certifications and repeatable manufacturing processes accumulate; the latter requires credit-worthy counterparties and attractive financing terms. Fazen recommends that investors demanding exposure to SMR growth seek instruments that provide downside protection on execution—for example through staged commitments tied to commissioning milestones—rather than a full upfront equity bet based solely on long-term sector narratives. (See additional Fazen thematic research on energy transition and infrastructure topic and our broader energy sector perspectives at topic.)

Outlook

Near-term, the market will focus on discrete milestones: NRC approvals, final investment decisions (FIDs) on first projects, and concrete, bankable offtake agreements. A string of positive milestones could shorten the time horizon for a $120 re-rating from many years to perhaps the 2027–2030 window; conversely, missed milestones would push realistic upside further into the 2030s. For most institutional investors, incremental evidence of project delivery and financing is required before materially increasing allocation to the equity.

Over a multi-year horizon, NuScale’s valuation will hinge on the scale and repeatability of deployments. If the company can capture a meaningful share of an SMR build-out measured in the low-to-mid gigawatts over a decade, valuations consistent with $120 per share become more plausible. However, investors should treat such scenarios probabilistically and apply conservative discount rates until the company demonstrates a delivery track record that mitigates early-adopter risk.

Bottom Line

A $120 target for NuScale is contingent on multiple execution and policy successes; it is achievable only if the company converts pipeline visibility into bankable, long-tenor contracts and delivers first-of-a-kind units on budget and on time. Absent those milestones, the market is likely to remain cautious and continue to price in execution risk.

FAQ

Q: What would a $120 share price imply for NuScale’s market capitalization? How should investors interpret that number?

A: Using an illustrative fully diluted share count of 135 million, $120 implies roughly a $16.2bn equity value (120 x 135m = $16.2bn). That figure should be interpreted as a headline check: it converts per-share rhetoric into a scale that investors can compare to utility acquirers, EPC businesses, and the total addressable SMR market. Confirm the company’s reported shares outstanding in the latest SEC filings to refine the market-cap estimate.

Q: Which specific milestones would most meaningfully de-risk a $120 scenario?

A: The most de-risking events are: (1) execution of FIDs with financing from credit-worthy lenders or export-credit agencies; (2) NRC licensing milestones completed without significant additional conditions; and (3) multi-decade offtake contracts with investment-grade counterparties or equivalent public guarantees. Each milestone reduces the likelihood of cost overruns and shortens the expected timeline to cash generation.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.